 Drug Industry
"Drug Industry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
| Descriptor ID |
D004345
|
| MeSH Number(s) |
J01.576.318
|
| Concept/Terms |
Drug Industry- Drug Industry
- Pharmaceutical Industry
- Industry, Pharmaceutic
- Industries, Pharmaceutic
- Pharmaceutic Industries
- Pharmaceutic Industry
- Industry, Drug
- Drug Industries
- Industries, Drug
- Industry, Pharmaceutical
- Industries, Pharmaceutical
- Pharmaceutical Industries
|
Below are MeSH descriptors whose meaning is more general than "Drug Industry".
Below are MeSH descriptors whose meaning is more specific than "Drug Industry".
This graph shows the total number of publications written about "Drug Industry" by people in UAMS Profiles by year, and whether "Drug Industry" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 | | 2020 | 0 | 2 | 2 | | 2019 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 | | 2013 | 1 | 0 | 1 | | 2012 | 1 | 0 | 1 | | 2010 | 3 | 1 | 4 | | 2009 | 2 | 0 | 2 | | 2008 | 1 | 1 | 2 | | 2007 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2005 | 4 | 0 | 4 | | 2004 | 2 | 0 | 2 | | 2003 | 1 | 0 | 1 | | 2002 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Industry" by people in Profiles over the past ten years.
-
Persaud S, Al Hadidi S, Anderson TS, Gallagher G, Chimonas S, Korenstein D, Mitchell AP. Industry Payments to Physicians Endorsing Drugs and Devices on a Social Media Platform. JAMA. 2024 06 25; 331(24):2131-2134.
-
Pakanati KC, Siddamreddy S, Nalleballe K, Thombre V, Sheng S, Veerapaneni K, Yadala S, Kapoor N, Dandu V, Avula A, Meegada S, Bere P. Industry payments to hospitalist physicians: a 5-year analysis of the Open Payments programme from 2014 to 2018. Intern Med J. 2020 Dec; 50(12):1547-1550.
-
Nalleballe K, Sheng S, Li C, Mahashabde R, Annapureddy AR, Mudassar K, Pothineni K, Veerapaneni P, Harada Y, Chilkulwar A, Ranabothu S, Brown A, Kapoor N, Onteddu S. Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018. Stroke. 2020 04; 51(4):1339-1343.
-
Yauk CL, Harrill AH, Ellinger-Ziegelbauer H, van der Laan JW, Moggs J, Froetschl R, Sistare F, Pettit S. A cross-sector call to improve carcinogenicity risk assessment through use of genomic methodologies. Regul Toxicol Pharmacol. 2020 Feb; 110:104526.
-
Pang WK, Yeter KC, Torralba KD, Spencer HJ, Khan NA. Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials. Int J Rheum Dis. 2015 Jul; 18(6):606-15.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|